Tonka
Well-known member
Posted on the Pediatric SuperSite on October 25, 2010
Children with HIV responded suboptimally to novel adjuvanted influenza A (H1N1) vaccine
VANCOUVER ? Less than 70% of children with HIV achieved seroprotection from the AS03-adjuvanted pandemic influenza A (H1N1) vaccine (Arepanrix, GlaxoSmithKline), according to findings presented at the 48th Annual Meeting of the Infectious Diseases Society of America.
Jason C. Brophy, MD, MSc, of the Division of Infectious Diseases in the Department of Pediatrics at Children?s Hospital of Eastern Ontario in Ottawa, and colleagues prospectively assessed vaccine responses in 78 children from two pediatric HIV clinics in Ontario. They performed hemagglutination inhibition titers at baseline and at 8 weeks after vaccination.
More-
http://www.pediatricsupersite.com/view.aspx?rid=76920
Children with HIV responded suboptimally to novel adjuvanted influenza A (H1N1) vaccine
VANCOUVER ? Less than 70% of children with HIV achieved seroprotection from the AS03-adjuvanted pandemic influenza A (H1N1) vaccine (Arepanrix, GlaxoSmithKline), according to findings presented at the 48th Annual Meeting of the Infectious Diseases Society of America.
Jason C. Brophy, MD, MSc, of the Division of Infectious Diseases in the Department of Pediatrics at Children?s Hospital of Eastern Ontario in Ottawa, and colleagues prospectively assessed vaccine responses in 78 children from two pediatric HIV clinics in Ontario. They performed hemagglutination inhibition titers at baseline and at 8 weeks after vaccination.
More-
http://www.pediatricsupersite.com/view.aspx?rid=76920